PARKERS PHARMA LIMITED

Company Registration Number:
11741150 (England and Wales)

Unaudited statutory accounts for the year ended 31 December 2025

Period of accounts

Start date: 1 January 2025

End date: 31 December 2025

PARKERS PHARMA LIMITED

Contents of the Financial Statements

for the Period Ended 31 December 2025

Directors report
Profit and loss
Balance sheet
Additional notes
Balance sheet notes

PARKERS PHARMA LIMITED

Directors' report period ended 31 December 2025

The directors present their report with the financial statements of the company for the period ended 31 December 2025

Additional information

The director presents his report and accounts for the year ended 31 December 2025. Statement of directors' responsibilities The directors are responsible for preparing the report and accounts in accordance with applicable law and regulations. Company law requires the directors to prepare accounts for each financial year. Under that law, the directors have elected to prepare the accounts in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the accounts unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these accounts, the directors are required to: - select suitable accounting policies and then apply them consistently; - make judgements and estimates that are reasonable and prudent; - prepare the accounts on the going concern basis unless it is inappropriate to presume that the company will continue in business. The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the accounts comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. Small company provisions This report has been prepared in accordance with the special provisions relating to small companies within Part 15 of the Companies Act 2006.



Directors

The director shown below has held office during the whole of the period from
1 January 2025 to 31 December 2025

Dr Wathek Zair

The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
23 October 2026

And signed on behalf of the board by:
Name: Dr Wathek Zair
Status: Director

PARKERS PHARMA LIMITED

Profit And Loss Account

for the Period Ended 31 December 2025

2025 2024


£
£
Turnover: 1,208,392 1,370,186
Cost of sales: ( 691,087 ) ( 1,136,379 )
Gross profit(or loss): 517,305 233,807
Administrative expenses: ( 513,915 ) ( 207,171 )
Other operating income: 0 108,471
Operating profit(or loss): 3,390 135,107
Interest payable and similar charges: 0 ( 2,516 )
Profit(or loss) before tax: 3,390 132,591
Tax: 0 0
Profit(or loss) for the financial year: 3,390 132,591

PARKERS PHARMA LIMITED

Balance sheet

As at 31 December 2025

Notes 2025 2024


£
£
Fixed assets
Tangible assets: 3 319,552 199,977
Total fixed assets: 319,552 199,977
Creditors: amounts falling due within one year: 4 ( 650 ) ( 500 )
Net current assets (liabilities): (650) (500)
Total assets less current liabilities: 318,902 199,477
Creditors: amounts falling due after more than one year: 5 ( 282,630 ) ( 166,595 )
Total net assets (liabilities): 36,272 32,882
Capital and reserves
Called up share capital: 3,000 3,000
Profit and loss account: 33,272 29,882
Total Shareholders' funds: 36,272 32,882

The notes form part of these financial statements

PARKERS PHARMA LIMITED

Balance sheet statements

For the year ending 31 December 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 23 October 2026
and signed on behalf of the board by:

Name: Dr Wathek Zair
Status: Director

The notes form part of these financial statements

PARKERS PHARMA LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2025

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Other accounting policies

    Statutory information PARKERS PHARMA LIMITED is a private company, limited by shares, registered in England and Wales, registration number 11741150. The registered office is Bartle House, 9 Oxford Court, Manchester, Lancashire, M2 3WQ, England. Compliance with accounting standards The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard. Accounting policies The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts. Basis of preparation The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets. Presentation currency The accounts are presented in £ sterling.

PARKERS PHARMA LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2025

  • 2. Employees

    2025 2024
    Average number of employees during the period 10 10

PARKERS PHARMA LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2025

3. Tangible assets

Land & buildings Plant & machinery Fixtures & fittings Office equipment Motor vehicles Total
Cost £ £ £ £ £ £
At 1 January 2025 9,547 260,685 3,631 0 273,863
Additions 223,581 2,106 23,417 249,104
Disposals
Revaluations
Transfers
At 31 December 2025 9,547 484,266 5,737 23,417 522,967
Depreciation
At 1 January 2025 7,161 65,171 1,554 0 73,886
Charge for year 2,386 121,066 1,394 4,683 129,529
On disposals
Other adjustments
At 31 December 2025 9,547 186,237 2,948 4,683 203,415
Net book value
At 31 December 2025 0 298,029 2,789 18,734 319,552
At 31 December 2024 2,386 195,514 2,077 0 199,977

All tangible asset categories are stated at cost. The office equipment column comprises computer equipment.

PARKERS PHARMA LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2025

4. Creditors: amounts falling due within one year note

2025 2024
£ £
Accruals and deferred income 650 500
Total 650 500

PARKERS PHARMA LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2025

5. Creditors: amounts falling due after more than one year note

2025 2024
£ £
Other creditors 282,630 166,595
Total 282,630 166,595